Metraipolis › archive › dc_48802deff876

Remarkable response to pembrolizumab in PD-L1 overexpressing (≥ 50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: a case report — Europe PMC PMID:41458605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41458605
DOI
10.3389/fonc.2025.1652515
License (as archived)
solo-consultazione
Archived
2026-11-07T16:26:10.089Z
SHA-256 of the archived text
f5e17ef661f1c38bbb6267cf21ec5d8857cc9466417556798fc3c4d2ee9a2791
Stable URL of this page
https://metraipolis.com/documento/dc_48802deff876

How to cite

Remarkable response to pembrolizumab in PD-L1 overexpressing (≥ 50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: a case report — Europe PMC PMID:41458605 — Europe PMC (en), https://europepmc.org/article/MED/41458605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48802deff876 (Metraipolis archive dc_48802deff876, sha256 f5e17ef661f1c38bbb6267cf21ec5d8857cc9466417556798fc3c4d2ee9a2791)
BibTeX
@misc{dc48802deff876,
  title = {Remarkable response to pembrolizumab in PD-L1 overexpressing (≥ 50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: a case report — Europe PMC PMID:41458605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41458605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48802deff876; sha256 f5e17ef661f1c38bbb6267cf21ec5d8857cc9466417556798fc3c4d2ee9a2791},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458605. Agents can read the archived copy with the MCP tool read_document.